Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction?

This publication has 10 references indexed in Scilit:

• CB₁ cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction
  British Journal of Pharmacology, 2003
• Cardiovascular effects of cannabinoids
  Pharmacology & Therapeutics, 2002
• Evidence of a novel site mediating anandamide‐induced negative inotropic and coronary vasodilatator responses in rat isolated hearts
  British Journal of Pharmacology, 2002
• Endogenous cannabinoids mediate hypotension after experimental myocardial infarction
  Journal of the American College of Cardiology, 2001
• Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide
  British Journal of Pharmacology, 2001
• Biosynthesis and inactivation of endocannabinoids: Relevance to their proposed role as neuromodulators
  Life Sciences, 1999
• Cardiovascular actions of cannabinoids and their generation during shock
  Journal of Molecular Medicine, 1998
• The actions of the cannabinoid receptor antagonist, SR 141716A, in the rat isolated mesenteric artery
  British Journal of Pharmacology, 1998
• Early Versus Delayed Angiotensin-Converting Enzyme Inhibition Therapy in Acute Myocardial Infarction
  Circulation, 1997
• Prevention of ventricular remodelling post myocardial infarction: timing and duration of therapy.
  1993